{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:52:29Z","timestamp":1787597549288,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anxiety, an important factor that affects the therapeutic effect and preservation rate of methadone maintenance treatment, has a high prevalence among MMT patients. This study aims to investigate the effects of treatment status and life quality on anxiety in MMT patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred and Seventy-seven methadone maintenance treatment users in Guangzhou, China were evaluated. The socio-demographic, duration and MMT-related characteristics were documented. Anxiety level and quality of life were evaluated by Beck Anxiety inventory (BAI) and the Quality of Life-Drug Addiction (QOL-DA) respectively. The correlation between different factors and BAI score was also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The BAI total score and the QOL-DA score were 7.1\u00b18.2, 163.5\u00b121.4 respectively. 30.5% of the subjects showed mild to severe anxiety. Treatment interruption and QOL-DA score had strong correlations with the score of BAI, with correlation coefficients of 0.17 and \u2212\u20090.08 respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anxiety symptoms were commonly presented in MMT patients. Treatment interruption and quality of life are two major factors affecting anxiety of MMT patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-021-00343-4","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T06:05:42Z","timestamp":1610517942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of treatment status and life quality on anxiety in MMT patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Penghui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-3174","authenticated-orcid":false,"given":"Ni","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"343_CR1","unstructured":"United Nations. World Drug Report 2019. (2019)."},{"key":"343_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710\u201326. https:\/\/doi.org\/10.1038\/nrd897.","journal-title":"Nat Rev Drug Discov"},{"key":"343_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/her\/13.1.87","volume":"13","author":"MC Shediac-Rizkallah","year":"1998","unstructured":"Shediac-Rizkallah MC, Bone LR. Planning for the sustainability of community-based health programs: conceptual frameworks and future directions for research, practice and policy. Health Educ Res. 1998;13:87\u2013108. https:\/\/doi.org\/10.1093\/her\/13.1.87.","journal-title":"Health Educ Res"},{"key":"343_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2471\/blt.11.086850","volume":"89","author":"M Kermode","year":"2011","unstructured":"Kermode M, Crofts N, Kumar MS, Dorabjee J. Opioid substitution therapy in resource-poor settings. Bull World Health Organ. 2011;89:243. https:\/\/doi.org\/10.2471\/blt.11.086850.","journal-title":"Bull World Health Organ"},{"key":"343_CR5","doi-asserted-by":"publisher","unstructured":"Tran BX, et al. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016;13(4). https:\/\/doi.org\/10.1186\/s12954-016-0091-4.","DOI":"10.1186\/s12954-016-0091-4"},{"key":"343_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/ADM.0b013e318156cc19","volume":"1","author":"J Shi","year":"2007","unstructured":"Shi J, et al. The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in china. J Addict Med. 2007;1:186\u201390. https:\/\/doi.org\/10.1097\/ADM.0b013e318156cc19.","journal-title":"J Addict Med"},{"key":"343_CR7","unstructured":"National Narcotics Control Commission. Annual Report on Drug Control in China 2019. (2020)."},{"issue":"Suppl 1","key":"343_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/add.12780","volume":"110","author":"W Yin","year":"2015","unstructured":"Yin W, et al. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction. 2015;110(Suppl 1):51\u201360. https:\/\/doi.org\/10.1111\/add.12780.","journal-title":"Addiction"},{"key":"343_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/0004867010060507","volume":"35","author":"T Callaly","year":"2001","unstructured":"Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry. 2001;35:601\u20135. https:\/\/doi.org\/10.1080\/0004867010060507.","journal-title":"Aust N Z J Psychiatry"},{"issue":"in Chinese","key":"343_CR10","first-page":"13","volume":"881\u2013884","author":"CW TANG Cai-yun","year":"2012","unstructured":"TANG Cai-yun CW, Ying-Hua X, Xia Z, Li L. Study on the impact of community-based methadone maintenance treatment on anxiety and depression of opioid addicts. Chin Prevent Med. 2012;881\u2013884(in Chinese):13.","journal-title":"Chin Prevent Med"},{"key":"343_CR11","unstructured":"XU Huili, L. Y., ZHANG Jing, XIE Meiying, CHEN Guolan, LIU Yinhua, XU Wei. Comorbidity Of Psychiatric Disorder In Individuals With Methadone Maintenance Treatment. Chin J Drug Depend 22, 197\u2013199+219. ( in Chinese) (2013)."},{"key":"343_CR12","doi-asserted-by":"crossref","unstructured":"Anh LT, et al. Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam. Subst Abuse Treat Prevent Policy. 2019:14.","DOI":"10.1186\/s13011-019-0223-4"},{"key":"343_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/09540121.2016.1255705","volume":"29","author":"M Jiao","year":"2017","unstructured":"Jiao M, et al. Resilience associated with mental health problems among methadone maintenance treatment patients in Guangzhou, China. AIDS Care. 2017;29:660\u20135. https:\/\/doi.org\/10.1080\/09540121.2016.1255705.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"343_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/appy.12069","volume":"5","author":"A Baharudin","year":"2013","unstructured":"Baharudin A, Mislan N, Ibrahim N, Sidi H, Nik Jaafar NR. Depression in male patients on methadone maintenance therapy. Asia Pac Psychiatry. 2013;5(Suppl 1):67\u201373. https:\/\/doi.org\/10.1111\/appy.12069.","journal-title":"Asia Pac Psychiatry"},{"key":"343_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00007691-200208000-00001","volume":"24","author":"K Wolff","year":"2002","unstructured":"Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit. 2002;24:457\u201370. https:\/\/doi.org\/10.1097\/00007691-200208000-00001.","journal-title":"Ther Drug Monit"},{"key":"343_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1037\/\/1064-1297.10.1.39","volume":"10","author":"MK Greenwald","year":"2002","unstructured":"Greenwald MK. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. Exp Clin Psychopharmacol. 2002;10:39\u201346. https:\/\/doi.org\/10.1037\/\/1064-1297.10.1.39.","journal-title":"Exp Clin Psychopharmacol"},{"key":"343_CR17","doi-asserted-by":"publisher","unstructured":"Xu YM, Zhong BL, Chen WC, Zhu JH, Lu J. Suicidal ideation among Chinese methadone-maintained patients: prevalence and correlates. Oncotarget, 8. 2017:86181\u20137. https:\/\/doi.org\/10.18632\/oncotarget.21032.","DOI":"10.18632\/oncotarget.21032"},{"key":"343_CR18","doi-asserted-by":"crossref","unstructured":"Richard S, Kim W, Jane ME, John S. Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev. 2009;28.","DOI":"10.1111\/j.1465-3362.2009.00064.x"},{"key":"343_CR19","doi-asserted-by":"crossref","unstructured":"Bruna B, et al. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008:27.","DOI":"10.1080\/10550880802122620"},{"issue":"Suppl 11","key":"343_CR20","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.1002\/acr.20561","volume":"63","author":"LJ Julian","year":"2011","unstructured":"Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S467\u201372. https:\/\/doi.org\/10.1002\/acr.20561.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"343_CR21","doi-asserted-by":"crossref","unstructured":"Beck AT, N E, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988:56.","DOI":"10.1037\/0022-006X.56.6.893"},{"key":"343_CR22","doi-asserted-by":"publisher","unstructured":"Wan C, et al. Development and validation of a quality of life instrument for patients with drug dependence: comparisons with SF-36 and WHOQOL-100. Int J Nurs Stud, 48. 2011:1080\u201395. https:\/\/doi.org\/10.1016\/j.ijnurstu.2011.02.012.","DOI":"10.1016\/j.ijnurstu.2011.02.012"},{"key":"343_CR23","doi-asserted-by":"publisher","unstructured":"Zhu D, et al. Beneficial effects of Tai Chi for amphetamine-type stimulant dependence: a pilot study. Am J Drug Alcohol Abuse, 42. 2016:469, 478. https:\/\/doi.org\/10.3109\/00952990.2016.1153646.","DOI":"10.3109\/00952990.2016.1153646"},{"key":"343_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","volume":"30","author":"JC Veilleux","year":"2010","unstructured":"Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30:155\u201366. https:\/\/doi.org\/10.1016\/j.cpr.2009.10.006.","journal-title":"Clin Psychol Rev"},{"key":"343_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/15622975.2011.561872","volume":"12","author":"M Soyka","year":"2011","unstructured":"Soyka M, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry. 2011;12:160\u201387. https:\/\/doi.org\/10.3109\/15622975.2011.561872.","journal-title":"World J Biol Psychiatry"},{"key":"343_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drugalcdep.2011.01.004","volume":"117","author":"C Lin","year":"2011","unstructured":"Lin C, Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug Alcohol Depend. 2011;117:45\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.01.004.","journal-title":"Drug Alcohol Depend"},{"key":"343_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10550880903436010","volume":"29","author":"A Fareed","year":"2010","unstructured":"Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis. 2010;29:1\u201314. https:\/\/doi.org\/10.1080\/10550880903436010.","journal-title":"J Addict Dis"},{"key":"343_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1521-0391.2013.00334.x","volume":"22","author":"S Iskandar","year":"2013","unstructured":"Iskandar S, et al. Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia. Am J Addict. 2013;22:425\u201331. https:\/\/doi.org\/10.1111\/j.1521-0391.2013.00334.x.","journal-title":"Am J Addict"},{"key":"343_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/10550490903205652","volume":"18","author":"PJ Carpentier","year":"2009","unstructured":"Carpentier PJ, et al. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18:470\u201380. https:\/\/doi.org\/10.3109\/10550490903205652.","journal-title":"Am J Addict"},{"key":"343_CR30","doi-asserted-by":"crossref","unstructured":"G FH, P BS, Cindy M, H SS. The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients. Harm Reduct J, 8. 2011.","DOI":"10.1186\/1477-7517-8-18"},{"key":"343_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.kjms.2010.09.003","volume":"27","author":"CN Yen","year":"2011","unstructured":"Yen CN, Wang CS, Wang TY, Chen HF, Chang HC. Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci. 2011;27:177\u201383. https:\/\/doi.org\/10.1016\/j.kjms.2010.09.003.","journal-title":"Kaohsiung J Med Sci"},{"key":"343_CR32","doi-asserted-by":"publisher","unstructured":"Zhang X, et al. Depression, suicidal ideation, and related factors of methadone maintenance treatment users in Guangzhou, China. AIDS Care, 28. 2016:851\u20136. https:\/\/doi.org\/10.1080\/09540121.2015.1124981.","DOI":"10.1080\/09540121.2015.1124981"},{"key":"343_CR33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/s0140-6736(11)60893-3","volume":"380","author":"YT Xiang","year":"2012","unstructured":"Xiang YT, Yu X, Sartorius N, Ungvari GS, Chiu HF. Mental health in China: challenges and progress. Lancet. 2012;380:1715\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(11)60893-3.","journal-title":"Lancet"},{"key":"343_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/ADM.0b013e3181ee77cl","volume":"5","author":"DT Barry","year":"2011","unstructured":"Barry DT, et al. Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want? J Addict Med. 2011;5:181\u20137. https:\/\/doi.org\/10.1097\/ADM.0b013e3181ee77cl.","journal-title":"J Addict Med"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-021-00343-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T06:26:52Z","timestamp":1610519212000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00343-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-90820\/v1","asserted-by":"object"}]},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"2 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IRB, Guangzhou Huiai Hospital approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}